Rapidly and successful improvement of nail psoriasis with risankizumab

This clinical case demonstrates quick resolution of nail psoriasis in a patient treated with risankizumab, highlighting the role of IL‐23 in the pathogenesis of nail psoriasis.

Detalles Bibliográficos
Autores principales: Orsini, Diego, Pacifico, Alessia, Iacovelli, Paolo, Frascione, Pasquale, De Simone, Paola, Assorgi, Chiara, Pigliacelli, Flavia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562652/
https://www.ncbi.nlm.nih.gov/pubmed/37822482
http://dx.doi.org/10.1002/ccr3.8035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562652/
https://www.ncbi.nlm.nih.gov/pubmed/37822482
http://dx.doi.org/10.1002/ccr3.8035

Ejemplares similares